Key Advantages

The Algernon Value Proposition

  • Advancing new drug treatments for billion dollar global disease markets.


  • Advancing 3 lead compounds that either out performed or matched the gold standard of care treatment or one the leading drugs under development, in repeated animal in vivo studies. See our Pipeline


  • In the planning stages for 3 separate phase II clinical trials.


  • Highly capital efficient business model.


  • Experienced management team.